Opening Asia for Russia

Thailand is waiting for the supply of two vaccines against COVID-19 at once

24.02.2021 113 просмотров

Thailand on February 24 will receive two vaccines from coronavirus from Sinovac and AstraZeneca.


The first batches of two coronavirus vaccines at once - the Chinese company Sinovac (Sinovac) and the British-Swedish consortium AstraZeneca (AstraZeneca) - will arrive on Wednesday in Thailand. This was announced on Tuesday on his Facebook page by the Minister of Health of the Kingdom Anutin Charnveerakul.


"First batches of vaccines from Sinovac and AstraZeneca will arrive in Thailand tomorrow, " he wrote. “ The total number of doses will be 400,000.” This post comes hours after the minister clarified that Prime Minister Prayut Chan-Ocha would be among the first to be vaccinated with AstraZeneca and not CoronaVac. Both vaccines have already been approved for emergency use by the Food and Drug Administration of Thailand.


Since November last year, the Thai authorities have been negotiating the manufacture of the AstraZeneca vaccine in the territory of the kingdom. During 2021, Siam Bioscience is expected to produce 200 million doses of the coronavirus drug, of which more than 60 million doses have been reserved by the Thai government. In January, the local regulator approved the use of an imported version of this vaccine made in Italy. It was assumed that the first 50 & nbsp; thousand. doses of the drug will be delivered to the kingdom in February, and the remaining 150,000. doses - in March-April, but later it became known that the vaccine would be brought from Asia, without specifying the dates.


In February, the prime minister of the kingdom announced that the delivery of a vaccine manufactured by Sinovac is expected at the end of the month. The drug was approved for emergency use two days before its arrival in the country on February 22. Thus, 200 & nbsp; thousand. doses of CoronaVac will be delivered on February 24, another 800,000 — in March and million —in April. The main group of people who will be the first to receive the drug includes healthcare workers who have close contacts with people infected with coronavirus, people with chronic diseases, and people aged 60 and over.


Новости партнёров